SCHEMBL14887583

SCHEMBL14887583

Cc1cc2c(cc1-c1ccc(NC(=O)c3conc3C)cc1)OC(F)(F)O2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 2/20 0.43
▸ POLQ O75417 1/20 0.42
▸ STIM1 Q13586 1/20 0.41
▸ ORAI1 Q96D31 1/20 0.41
▸ SCN10A Q9Y5Y9 4/20 0.39
▸ IL2 P60568 2/20 0.38
▸ ADORA3 P0DMS8 1/20 0.37
▸ ADORA2A P29274 1/20 0.37
▸ ADORA2B P29275 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ GCGR P47871 1/20 0.37
▸ F2 P00734 2/20 0.37
▸ F10 P00742 2/20 0.37
▸ KMT2A Q03164 1/20 0.36
▸ TAS2R8 Q9NYW2 1/20 0.36
▸ CSNK1D P48730 2/20 0.36
▸ CSNK1E P49674 2/20 0.36
▸ SCN5A Q14524 1/20 0.36
▸ SCN2A Q99250 1/20 0.36
▸ SCN3A Q9NY46 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14887576 0.90 SCN10A (0.44) SCN9APOLQSTIM1ORAI1SCN10A
SCHEMBL16020567 0.88 STIM1 (0.51) SCN9APOLQSTIM1ORAI1SCN10A
SCHEMBL16017232 0.84 SCN9A (0.45) SCN9APOLQSTIM1ORAI1IL2
SCHEMBL14887348 0.83 SCN9A (0.43) SCN9APOLQSTIM1ORAI1IL2
SCHEMBL17805358 0.82 SMN1; SMN2 (0.51) SCN9AKMT2A
SCHEMBL16017226 0.81 SCN9A (0.45) SCN9APOLQSTIM1ORAI1IL2
SCHEMBL14881326 0.81 GFER (0.52) KMT2ATAS2R8
SCHEMBL14881301 0.81 MEN1 (0.53) SCN9ASTIM1ORAI1IL2KMT2A
SCHEMBL14887577 0.80 HSD17B10 (0.55) SCN9ASTIM1ORAI1IL2KMT2A
SCHEMBL16020562 0.79 STIM1 (0.52) SCN9APOLQSTIM1ORAI1SCN10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 — — US disclosed
WO-2013059666-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2013-04-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 SCN9A 235/4885POLQ 4725/4885STIM1 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback